Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against ViewRay, Inc. (VRAY) and November 12 Deadline

November 5, 2019 GMT

NEW YORK--(BUSINESS WIRE)--Nov 5, 2019--

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against ViewRay, Inc. (“ViewRay” or the “Company”) (NASDAQ: VRAY), and certain other defendants, related to alleged violations of federal securities laws. If you purchased ViewRay common stock between March 15, 2019 to August 8, 2019, you are encouraged to contact a Scott+Scott attorney at (888) 398-9312 for more information. The lead plaintiff deadline is November 12, 2019.

ViewRay specializes in the development of MRI-guided radiation therapy (“MRgRT”) technology for the treatment of cancer.

The lawsuit alleges that defendants issued materially false and misleading statements that failed to disclose adverse facts concerning ViewRay’s business, operations, and financial results. Specifically, defendants failed to disclose: (a) that demand for ViewRay systems had declined due in part to changes being made to Medicare reimbursement approaches first announced in November 2019 that could make purchases of new ViewRay systems less profitable for customers; (b) that ViewRay’s reported backlog was overstated due to the inclusion of orders with insufficient surety as to permit for their inclusion in reported backlog; and (c) that as a result of the foregoing, defendants’ positive statements about ViewRay’s business metrics and financial prospects during the Class Period were materially false and misleading and/or lacked a reasonable basis.

On August 8, 2019, after the close of trading, ViewRay disclosed operational issues and slashed its previously issued full fiscal year 2019 financial guidance.

On this news, the price of ViewRay common stock price dropped $3.64 per share – over 50% – to close at $3.10 on August 9, 2019.

What You Can Do

If you purchased ViewRay stock between March 15, 2019 to August 8, 2019, inclusive, or if you have questions about this notice or your legal rights, you are encouraged to contact attorney Jonathan Zimmerman at (888) 398-9312 or jzimmerman@scott-scott.com.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

Attorney Advertising

View source version on businesswire.com:https://www.businesswire.com/news/home/20191105005345/en/

CONTACT: Jonathan Zimmerman

Scott+Scott Attorneys at Law LLP

230 Park Avenue, 17 Floor, New York, NY 10169-1820

(888) 398-9312




SOURCE: Scott+Scott Attorneys at Law LLP

Copyright Business Wire 2019.

PUB: 11/05/2019 09:40 AM/DISC: 11/05/2019 09:40 AM